United States Food and Drug Administration

"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.

Descriptor ID	D014486
MeSH Number(s)	I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
Concept/Terms	United States Food and Drug Administration United States Food and Drug Administration United States Food, Drug Administration USFDA Food and Drug Administration (U.S.) Food and Drug Administration

Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".

Anthropology, Education, Sociology and Social Phenomena [I]
Social Sciences [I01]
Government [I01.409]
Government Agencies [I01.409.418]
United States Government Agencies [I01.409.418.750]
United States Dept. of Health and Human Services [I01.409.418.750.600]
United States Public Health Service [I01.409.418.750.600.650]
United States Food and Drug Administration [I01.409.418.750.600.650.760]
Health Care [N]
Health Care Economics and Organizations [N03]
Organizations [N03.540]
Government [N03.540.348]
Federal Government [N03.540.348.500]
United States Government Agencies [N03.540.348.500.500]
United States Dept. of Health and Human Services [N03.540.348.500.500.600]
United States Public Health Service [N03.540.348.500.500.600.650]
United States Food and Drug Administration [N03.540.348.500.500.600.650.760]

Below are MeSH descriptors whose meaning is related to "United States Food and Drug Administration".

Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.

Bar chart showing 90 publications over 26 distinct years, with a maximum of 11 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	2	2
1994	0	1	1
1997	0	1	1
1999	0	1	1
2000	0	2	2
2001	0	1	1
2002	0	1	1
2003	0	2	2
2004	0	5	5
2005	0	3	3
2006	0	2	2
2007	2	4	6
2008	0	2	2
2009	1	5	6
2010	0	3	3
2011	1	3	4
2012	2	4	6
2013	1	0	1
2014	2	4	6
2015	1	3	4
2016	3	8	11
2017	0	5	5
2018	1	3	4
2019	0	6	6
2020	1	3	4
2021	0	1	1

Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.

Goodman CW, Brett AS. Race and Pharmacogenomics-Personalized Medicine or Misguided Practice? JAMA. 2021 Feb 16; 325(7):625-626.

View in: PubMed
Bennett CL, Schoen MW, Hoque S, Witherspoon BJ, Aboulafia DM, Hwang CS, Ray P, Yarnold PR, Chen BK, Schooley B, Taylor MA, Wyatt MD, Hrushesky WJ, Yang YT. Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions. Lancet Oncol. 2020 12; 21(12):e575-e588.

View in: PubMed
Green SM, Norse AB, Jackson BF, Carman MJ, Roback MG. Regulatory Challenges to Emergency Medicine Procedural Sedation. Ann Emerg Med. 2021 01; 77(1):91-102.

View in: PubMed
Bennett AC, Bennett CL, Witherspoon BJ. Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency' by bennett et al. Expert Opin Drug Saf. 2020 08; 19(8):1057-1058.

View in: PubMed
Rollins-Raval MA, Marlar RA, Goodwin AJ. Age-Adjusted D-dimer Cutoffs: A Warning From the Laboratory. Ann Emerg Med. 2020 06; 75(6):783-784.

View in: PubMed
Campbell EH, Elston DM, Straughan CL, Antonovich DD. Regulations, liability, safety, and economics related to compounding. J Am Acad Dermatol. 2020 Jul; 83(1):184-188.

View in: PubMed
Bennett AC, Bennett CL, Witherspoon BJ, Knopf KB. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency. Expert Opin Drug Saf. 2019 Nov; 18(11):1055-1063.

View in: PubMed
Walker JR, Korte JE, McRae-Clark AL, Hartwell KJ. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population. J Stud Alcohol Drugs. 2019 09; 80(5):572-577.

View in: PubMed
Bennett CL, Schooley B, Taylor MA, Witherspoon BJ, Godwin A, Vemula J, Ausdenmoore HC, Sartor O, Yang YT, Armitage JO, Hrushesky WJ, Restaino J, Thomsen HS, Yarnold PR, Young T, Knopf KB, Chen B. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions. PLoS One. 2019; 14(7):e0219521.

View in: PubMed
Kellner CH, McCall WV, Spaans HP, Sienaert P. The FDA Final Order on ECT Devices, Finally. J ECT. 2019 06; 35(2):69-70.

View in: PubMed

People

Explore

Similar Concepts

Top Journals